New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SCYNEXIS, Inc.
SCYX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

45M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

45M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

1.18USD

Shape0.09 ( 8.26%)
sun-fogPre-market 1.20$arrow-right-up0.02 (1.69%)
Market Closed (as of Feb 05, 21:00 EDT)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

25%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated February 6, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

SCYX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$60M

Shape9031%

2025-Revenue

$0.37

Shape746%

2025-EPS

$18M

Shape-495%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Guggenheim

initialise

Previous: Not converted

2023-03-01

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.59
vs -1.05

Q1.23

arrow
arrow

N/A

-0.25
vs -0.51

Q2.23

arrow
arrow

+564%

2.46
vs -0.53

Q3.23

arrow
arrow

N/A

-0.04
vs -0.62

Q4.23

arrow
arrow

N/A

-0.39
vs -0.59

Q1.24

arrow
arrow

N/A

-0.15
vs -0.25

Q2.24

arrow
arrow

N/A

-0.30
vs 2.46

Q3.24

arrow
arrow

N/A

-0.06
vs -0.04

Q4.24

arrow
arrow

N/A

-0.02
vs -0.39

Q1.25

arrow
arrow

N/A

-0.05
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+155%

1.5M  vs 597K

Q1.23

arrow
arrow

+64%

1.1M  vs 687K

Q2.23

arrow
arrow

+9836%

131.5M  vs 1.3M

Q3.23

arrow
arrow

+13%

1.8M  vs 1.6M

Q4.23

arrow
arrow

+280%

5.8M  vs 1.5M

Q1.24

arrow
arrow

+22%

1.4M  vs 1.1M

Q2.24

arrow
arrow

-99%

736K  vs 131.5M

Q3.24

arrow
arrow

-63%

660K  vs 1.8M

Q4.24

arrow
arrow

+76%

10.2M  vs 5.8M

Q1.25

arrow
arrow

+363%

6.4M  vs 1.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-592%

-5.92
vs -2.16

Q1.23

arrow
arrow

+186%

1.86
vs -5.92

Q2.23

arrow
arrow

+131%

1.31
vs 1.86

Q3.23

arrow
arrow

-2%

-0.02
vs 1.31

Q4.23

arrow
arrow

-27%

-0.27
vs -0.02

Q1.24

arrow
arrow

+1%

0.01
vs -0.27

Q2.24

arrow
arrow

-24%

-0.24
vs 0.01

Q3.24

arrow
arrow

-5%

-0.05
vs -0.24

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

43

43
vs 43

NA

Q1.23

arrow
arrow

60

60
vs 43

40%

Q2.23

arrow
arrow

55

55
vs 60

-8%

Q3.23

arrow
arrow

65

65
vs 55

18%

Q4.23

arrow
arrow

53

53
vs 65

-18%

Q1.24

arrow
arrow

54

54
vs 53

2%

Q2.24

arrow
arrow

55

55
vs 54

2%

Q3.24

arrow
arrow

45

45
vs 55

-18%

Earnings Growth

Latest News